HR 6513
117th Congress
House
Health
Administrative remedies
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Medical Innovation Acceleration Act of 2022
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 31, 2022
Referred to the Subcommittee on Health.
Jan 28, 2022
Referred to the House Committee on Energy and Commerce.
Jan 28, 2022
Introduced in House
Plain-English summary
Medical Innovation Acceleration Act of 2022
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2